Clinical Trial

Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis

Study acronym: PREDMETH
Unknown Phase 4
View on ClinicalTrials.gov →
Summary
This is a prospective, randomized, non-blinded, multi-center, non-inferiority trial designed to compare effectiveness and side-effects of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT04314193
Lead Sponsor Erasmus Medical Center
Collaborators: St. Antonius Hospital, Longfonds
Conditions Sarcoidosis, Pulmonary
Enrollment 138 participants
Start Date 2020-06-01
Primary Completion 2024-08-13 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-03-26